Nyxoah (NYXH) Consolidated Net Income (2021 - 2026)
Nyxoah's (NYXH) quarterly Consolidated Net Income came in at $18.2 million in Q1 2026, down 22.23% year-on-year from $23.4 million in Q1 2025, and down 99.93% quarter-over-quarter from $25.3 billion in Q4 2025.
Nyxoah (NYXH) Consolidated Net Income (2021 - 2026) Analysis & Trends
Nyxoah's Consolidated Net Income history runs 6 years deep, the most recent figure standing at $18.2 million for Q1 2026.
- On a quarterly basis, Consolidated Net Income fell 22.23% year-over-year to $18.2 million in Q1 2026; TTM through Mar 2026 was $25.3 billion, a 282.32% increase from a year earlier, with the FY2025 full-year figure at -$105.8 million, down 61.6% from the prior year.
- Consolidated Net Income fell to $18.2 million in Q1 2026 per NYXH's latest filing, from $25.3 billion in the prior quarter.
- Across five years, Consolidated Net Income topped out at $25.3 billion in Q4 2025 and bottomed at -$13.9 billion in Q4 2024.
- The 5-year median for Consolidated Net Income is -$6.2 million (2022), against an average of $15.5 million.
- Across the five-year window, Consolidated Net Income surged 1567.57% in 2022 and tumbled 175602.68% in 2023, its largest moves.
- Year by year, Consolidated Net Income stood at $13.6 billion in 2022, then sank by 191.57% to -$12.4 billion in 2023, then slipped by 11.74% to -$13.9 billion in 2024, then surged by 282.18% to $25.3 billion in 2025, then tumbled by 99.93% to $18.2 million in 2026.
- Per Business Quant, the three latest NYXH Consolidated Net Income figures stand at $18.2 million (Q1 2026), $25.3 billion (Q4 2025), and -$28.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 240.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Mn |
| Dec 31, 2025 | 25.29 Bn |
| Sep 30, 2025 | -28.24 Mn |
| Jun 30, 2025 | -22.70 Mn |
| Mar 31, 2025 | 23.41 Mn |
| Dec 31, 2024 | -13.88 Bn |
| Sep 30, 2024 | 18.73 Mn |
| Jun 30, 2024 | -13.18 Mn |
| Mar 31, 2024 | 132.31 Mn |
| Dec 31, 2023 | -12.42 Bn |
| Sep 30, 2023 | 8.29 Mn |
| Jun 30, 2023 | -11.91 Mn |
| Mar 31, 2023 | -12.39 Bn |
| Dec 31, 2022 | 13.57 Bn |
| Sep 30, 2022 | -6.16 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -7.05 Mn |
| Dec 31, 2021 | -924.33 Mn |
| Sep 30, 2021 | -10.01 Mn |
| Jun 30, 2021 | 8.12 Mn |